Search Results Search Sort by RelevanceMost Recent Letter to the Editor Jul 2020 Response to “How Should Global Tobacco Control Efforts Be Prioritized to Protect Children in Resource-Poor Regions?” A Deliberate Public Policy Plus Naivety at Best Alain Braillon, MD, PhD Do the WHO and health professionals simply fail to do their job adequately? AMA J Ethics. 2020;22(7):E639-642. doi: 10.1001/amajethics.2020.639. Letter to the Editor Jul 2020 Response to “A Deliberate Public Policy Plus Naivety at Best” Stella Aguinaga Bialous, DrPH and Yvette van der Eijk, PhD Debate continues on how to frame tobacco and nicotine product regulation from a children’s rights perspective. AMA J Ethics. 2020;22(7):E643-644. doi: 10.1001/amajethics.2020.643. Case and Commentary Feb 2016 Should Physicians Attempt to Persuade a Patient to Accept a Compromised Organ for Transplant? Andy A. Tully, MD, Geraldine C. Diaz, DO, and John F. Renz, MD, PhD Transplant physicians must respect indecisive patients’ autonomy while continuing to educate them during their progress towards transplantation. AMA J Ethics. 2016;18(2):101-107. doi: 10.1001/journalofethics.2017.18.2.ecas1-1602. Medical Education Aug 2020 What Clinicians and Health Professions Students Should Learn About How Pharmaceutical Marketing Influences Opioid Prescribing and Patient Outcomes Michael A. Erdek, MD, MA Key policy changes would better situate clinicians to prescribe care in ways that are ethical, safe, and effective. AMA J Ethics. 2020;22(8):E681-686. doi: 10.1001/amajethics.2020.681. State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687. Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702. Policy Forum Aug 2020 How Structural Violence, Prohibition, and Stigma Have Paralyzed North American Responses to Opioid Overdose Mark Tyndall, MD, ScD and Zoë Dodd, MES Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful. AMA J Ethics. 2020;22(8):E723-728. doi: 10.1001/amajethics.2020.723. Case and Commentary Feb 2022 ¿Debería un médico alguna vez violar los protocolos SWAT o TEMS durante un incidente con múltiples víctimas? Brandon Morshedi, MD, DPT and Faroukh Mehkri, DO AMA J Ethics. 2022;E120-125. doi: 10.1001/amajethics.2022.120. Policy Forum Feb 2022 ¿Cómo se debería equilibrar el riesgo para el personal táctico con los requerimientos clínicos y ética de rescate? Mollie V. Williams, MD, MPH and Olaitan Ajisafe, MD, PharmD AMA J Ethics. 2022;E140-144. doi: 10.1001/amajethics.2022.140. Case and Commentary Jun 2022 How Should Relief Organizations Fund Care of Patient-Asylees Who Have Cancer? Farrah J. Mateen, MD, PhD and Paul B. Spiegel, MD, MPH Several clinical and ethical dilemmas arise when caring for refugees with complex, costly, and chronic conditions. AMA J Ethics. 2022;24(6):E457-462. doi: 10.1001/amajethics.2022.457. Pagination First page « First Previous page ‹ Previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page Next › Last page Last »
Letter to the Editor Jul 2020 Response to “How Should Global Tobacco Control Efforts Be Prioritized to Protect Children in Resource-Poor Regions?” A Deliberate Public Policy Plus Naivety at Best Alain Braillon, MD, PhD Do the WHO and health professionals simply fail to do their job adequately? AMA J Ethics. 2020;22(7):E639-642. doi: 10.1001/amajethics.2020.639.
Letter to the Editor Jul 2020 Response to “A Deliberate Public Policy Plus Naivety at Best” Stella Aguinaga Bialous, DrPH and Yvette van der Eijk, PhD Debate continues on how to frame tobacco and nicotine product regulation from a children’s rights perspective. AMA J Ethics. 2020;22(7):E643-644. doi: 10.1001/amajethics.2020.643.
Case and Commentary Feb 2016 Should Physicians Attempt to Persuade a Patient to Accept a Compromised Organ for Transplant? Andy A. Tully, MD, Geraldine C. Diaz, DO, and John F. Renz, MD, PhD Transplant physicians must respect indecisive patients’ autonomy while continuing to educate them during their progress towards transplantation. AMA J Ethics. 2016;18(2):101-107. doi: 10.1001/journalofethics.2017.18.2.ecas1-1602.
Medical Education Aug 2020 What Clinicians and Health Professions Students Should Learn About How Pharmaceutical Marketing Influences Opioid Prescribing and Patient Outcomes Michael A. Erdek, MD, MA Key policy changes would better situate clinicians to prescribe care in ways that are ethical, safe, and effective. AMA J Ethics. 2020;22(8):E681-686. doi: 10.1001/amajethics.2020.681.
State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687.
Policy Forum Aug 2020 Ethical Imperatives to Overcome Stigma Against People With Substance Use Disorders VADM Jerome M. Adams, MD, MPH and Nora D. Volkow, MD Responding to opioid use disorder as a US public health crisis requires all clinicians to recognize addiction as a treatable disease. AMA J Ethics. 2020;22(8):E702-708. doi: 10.1001/amajethics.2020.702.
Policy Forum Aug 2020 How Structural Violence, Prohibition, and Stigma Have Paralyzed North American Responses to Opioid Overdose Mark Tyndall, MD, ScD and Zoë Dodd, MES Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful. AMA J Ethics. 2020;22(8):E723-728. doi: 10.1001/amajethics.2020.723.
Case and Commentary Feb 2022 ¿Debería un médico alguna vez violar los protocolos SWAT o TEMS durante un incidente con múltiples víctimas? Brandon Morshedi, MD, DPT and Faroukh Mehkri, DO AMA J Ethics. 2022;E120-125. doi: 10.1001/amajethics.2022.120.
Policy Forum Feb 2022 ¿Cómo se debería equilibrar el riesgo para el personal táctico con los requerimientos clínicos y ética de rescate? Mollie V. Williams, MD, MPH and Olaitan Ajisafe, MD, PharmD AMA J Ethics. 2022;E140-144. doi: 10.1001/amajethics.2022.140.
Case and Commentary Jun 2022 How Should Relief Organizations Fund Care of Patient-Asylees Who Have Cancer? Farrah J. Mateen, MD, PhD and Paul B. Spiegel, MD, MPH Several clinical and ethical dilemmas arise when caring for refugees with complex, costly, and chronic conditions. AMA J Ethics. 2022;24(6):E457-462. doi: 10.1001/amajethics.2022.457.